Page 4,692«..1020..4,6914,6924,6934,694..4,7004,710..»

Trips not needed; it’s all right here

Posted: Published on January 15th, 2014

Dunedin woman Debbie Green. Photo by Gregor Richardson. Ms Green (54) paid the travel and accommodation costs, and she feared others might not be able to afford to do the same. Her GP initially told her there was no treatment for a debilitating hand condition called Dupuytren's contracture. He said she had to wait until the fingers on the affected hand were twisted permanently at a 45-degree angle, and then she would probably receive surgery. Not satisfied, she searched online, and discovered the Waikato District Health Board performed low-level radiation treatment for the condition. It is not a cure - but a few X-ray sessions knocked the progression of the tissue tightening hand disease back by a decade or more and restored the use of her left hand. Previously, simple tasks such as driving and preparing food were painful - and it was only going to get worse. The treatment itself was free, but she paid about $2500 for accommodation and airfares for three trips to Hamilton in January, February, and April. She contacted the Otago Daily Times wanting to alert others to the existence of the treatment. Ms Green was astounded after ODT inquiries revealed the treatment had been … Continue reading

Posted in MS Treatment | Comments Off on Trips not needed; it’s all right here

York Region student earns grant to study cancer

Posted: Published on January 15th, 2014

Aurora Banner A PhD at 27? It is not out of the question for Katie Di Sebastiano. Ms Di Sebastiano, a University of Waterloo PhD student, who grew up in Newmarket and Aurora, is turning heads in the medical research world with her prostate cancer project. She was one of five students from across Canada who received a $40,000 graduate student award from Prostate Cancer Canada. Her research focuses on body changes that occur during prostate cancer treatment that can include weight gain and muscle loss. The award will allow her to focus on her work, she said, offering thanks to Prostate Cancer Canada and Constantine Karayannopoulos. Similar to many people, cancer touched Ms Di Sebastianos life when her mother was diagnosed while Ms Di Sebastiano was an undergraduate kinesiology student at McMaster University. Her mother is now a breast cancer survivor, Ms Di Sebastiano said. The Cardinal Carter Catholic High School alumnus thought she would pursue a career in physiotherapy, but realized she really loved the research aspect of her studies, which led her to pursue a graduate degree. See the article here: York Region student earns grant to study cancer … Continue reading

Posted in MS Treatment | Comments Off on York Region student earns grant to study cancer

New First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Spain

Posted: Published on January 15th, 2014

Hatfield, England (ots/PRNewswire) - Fycompa(R) (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), launches today in Spain. The new therapy is indicated for the adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.[1] Perampanel is the only licensed anti-epileptic drug (AED) to selectively target AMPA receptors, a protein in the brain which plays a critical role in the spread of seizures.[2] This mechanism of action is different to other, currently available AEDs. In addition, perampanel has the added benefit of convenient, once-daily dosing at bedtime[1] and, significantly, is the only new-generation partial epilepsy treatment approved to treat adolescents with epilepsy from launch. Epilepsy is one of the most common neurological conditions in the world.[3] Around 400,000 people in Spain live with the condition.[4] "Almost a third of people with partial epilepsy continue to experience seizures despite the treatment options currently available," commented Dr. Jos Serratosa, an Epileptologist at the Epilepsy Unit of the Fundacin Jimnez Daz University Hospital, Madrid. "New treatment options such as this are a welcome addition to doctors' epilepsy treatment armamentarium." Perampanel's reimbursement approval … Continue reading

Comments Off on New First-in-class Epilepsy Treatment Fycompa® (perampanel) Launches in Spain

Dr. Leigh Ann Scott to Open Irving Office to Provide Bio-Identical Hormone Therapy

Posted: Published on January 15th, 2014

Dallas, TX (PRWEB) January 15, 2014 Dr. Leigh Ann Scott has announced the opening of her new office in Irving to provide Bio-identical Hormone Replacement Therapy. Bio-identical hormones are a vital treatment option and medical science supports their use in improving overall health while diminishing the effects of aging. Most patients are surprised at how helpful they can be as part of an integrated program that focuses on wellness. Considering all available options helps patients achieve their goals of being healthy and feeling younger," she explained. Dr. Scott is devoted to understanding what her patients want and need. Her practice approach is to listen carefully to her patient's experiences, analyze their symptoms, and then determine the appropriate lab testing that will help pinpoint the "root cause" of why a patient feels a certain way. The result of this medical analysis is a specific detailed plan that will include natural supplement and hormonal alternatives tailored for each individual situation. Her understanding and knowledge of womens health helps her design the right protocol of hormone balance, nutrition, supplement support, weight management and if indicated, food sensitivity testing. Dr. Scott graduated Summa Cum Laude with a Bachelor degree in Zoology from Texas A&M … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Dr. Leigh Ann Scott to Open Irving Office to Provide Bio-Identical Hormone Therapy

Using progesterone for hot flashes shown safe for women’s cardiovascular health

Posted: Published on January 15th, 2014

PUBLIC RELEASE DATE: 15-Jan-2014 Contact: Dr. Jerilynn Prior jerilynn.prior@ubc.ca 604-875-5927 University of British Columbia Treatment with progesterone, a naturally occurring hormone that has been shown to alleviate severe hot flashes and night sweats in post-menopausal women, poses little or no cardiovascular risk, according to a new study by the University of British Columbia and Vancouver Coastal Health. The findings, published today in PLOS ONE, help to dispel a major impediment to widespread use of progesterone as a treatment for hot flashes and night sweats, said lead author Dr. Jerilynn C. Prior, a professor of endocrinology and the head of Centre for Menstrual Cycle and Ovulation Research. For decades, women used a combination of synthetic estrogen and progesterone to reduce the frequency and severity of hot flashes and night sweats, as well as to prevent osteoporosis. Use of this so-called "hormone replacement therapy" dropped dramatically after 2002, when a large study revealed that it increased risk of heart disease, breast cancer, strokes and other serious conditions. To evaluate the cardiovascular risk of using progesterone to alleviate symptoms, Prior and her collaborators recruited 110 healthy Vancouver-area women who had recently reached postmenopause (a year after the final menstruation), giving half of them … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Using progesterone for hot flashes shown safe for women’s cardiovascular health

Federal Agency Reviewing Trans-Exclusionary Insurance Policies

Posted: Published on January 15th, 2014

The Office of Personnel Management is reviewing the insurance policies currently offered to agency employees, evaluating whether or not to include transition-related care on future plans. The federal Office of Personnel Management is in the process of evaluating its healthcare benefit program offered to agency employees specifically looking into exclusions for transition-related care often sought by transgender workers. Should OPM opt to add transition-specific coverage to insurance policies for its more than 6,000 employees, it would become the first federal agency to do so. Transition-related care may consist of hormone replacement therapy, mental health services, and gender-confirming surgeries. These services, currently excluded under federal health insurance plans, can end up costing an individual tens of thousands of dollars out-of-pocket, putting the medically necessary treatment outside the financial reach of many of those who need it most. According to Federal Times, any changes to OPM's insurance policies will be shown as coverage options in future policy offerings. In the meantime, the U.S. Department ofHealth and Human Servicesis evaluating whether or not the exclusion of transition-related care in health insurance plans actually constitutes a violation of federal law. The agency's findings could lead to increased trans coverage in insurance plans nationwide. Read … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Federal Agency Reviewing Trans-Exclusionary Insurance Policies

Annamaria Mocciaro on future research avenues for stem cell research – Video

Posted: Published on January 15th, 2014

Annamaria Mocciaro on future research avenues for stem cell research This interview with Annamaria Mocciaro on the Future of stem cell research is part of the Futurium Talking Futures interview series. More information is avai... By: DigitalFutures2050 … Continue reading

Posted in Stem Cell Research | Comments Off on Annamaria Mocciaro on future research avenues for stem cell research – Video

stem cell research F6373525 B9FE 40FF 8A84 11B056987500 – Video

Posted: Published on January 15th, 2014

stem cell research F6373525 B9FE 40FF 8A84 11B056987500 By: Olivia Woodson … Continue reading

Posted in Stem Cell Research | Comments Off on stem cell research F6373525 B9FE 40FF 8A84 11B056987500 – Video

Stem cell guru walks out on Spanish science

Posted: Published on January 15th, 2014

A world leader in stem cell research is leaving the cutting-edge center he helped create in Barcelona due to a lack of support from the authorities in both Catalonia and Spain. Juan Carlos Izpisa, a Spanish biochemist who teaches at the Salk Institute in California and has earned numerous awards for his research into organ and tissue development, had helped found the Barcelona Regenerative Medicine Center (CMRB) in 2004, bringing Spain to the forefront of stem cell research. But now Izpisa is resigning from his director's post due to a lack of financial and political support from his two major public sponsors, the government of Spain and the regional government of Catalonia. Sources in the scientific community are blaming the move on "the cuts, political mediocrity and a lack of empathy from Madrid." They also note that Catalan premier Artur Mas met with Izpisa 18 months ago and assured him that he would put all available means at his disposal. Sources in the scientific community are blaming the move on "the cuts, political mediocrity and a lack of empathy from Madrid" According to sources familiar with the months-long negotiations, the decision to let Izpisa go originated in the Catalan government, … Continue reading

Posted in Stem Cell Research | Comments Off on Stem cell guru walks out on Spanish science

Australia takes genetic medicine leap

Posted: Published on January 15th, 2014

AAP A new system bought by Sydney's Garvan Institute can map the genetic makeup of 350 people a week. Australian medicine has taken a leap into the future with the purchase of a system that can quickly and cheaply map a person's genetic makeup. The new system bought by Sydney's Garvan Institute can map 350 people a week at a cost of $1000 each. This means doctors will receive quick feedback on the best way to treat cancer patients and scientists will have massive power to build an Australian genetic database. The system differs from current genetic testing in that it maps the entire genome rather than specific gene mutations such as BRCA1 and BRCA2 that cause breast and ovarian cancer. The first whole human genome was mapped more than a decade ago by an international team of scientists at a cost $1 billion. Garvan is one of a few organisations in the world to buy the HiSeq X Ten Sequencing System, according to an announcement in San Diego on Tuesday (Wednesday AEDT). "Over the next few years, we have an opportunity to learn as much about the genetics of human disease as we have learned in the history of … Continue reading

Comments Off on Australia takes genetic medicine leap

Page 4,692«..1020..4,6914,6924,6934,694..4,7004,710..»